Dilip Buildcon Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 14, 2025, 8:50 am

Competitors of Dilip Buildcon Ltd

All Competitor Stocks of Dilip Buildcon Ltd

Quarterly Result

Last Updated: August 1, 2025, 10:05 pm

Below is a detailed analysis of the quarterly data for Dilip Buildcon Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 2,620.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,096.00 Cr. (Mar 2025) to 2,620.00 Cr., marking a decrease of 476.00 Cr..
• For Expenses, as of Jun 2025, the value is 2,100.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2,435.00 Cr. (Mar 2025) to 2,100.00 Cr., marking a decrease of 335.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 521.00 Cr.. The value appears to be declining and may need further review. It has decreased from 661.00 Cr. (Mar 2025) to 521.00 Cr., marking a decrease of 140.00 Cr..
• For OPM %, as of Jun 2025, the value is 20.00%. The value appears to be declining and may need further review. It has decreased from 21.00% (Mar 2025) to 20.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 386.00 Cr.. The value appears strong and on an upward trend. It has increased from 86.00 Cr. (Mar 2025) to 386.00 Cr., marking an increase of 300.00 Cr..
• For Interest, as of Jun 2025, the value is 498.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 309.00 Cr. (Mar 2025) to 498.00 Cr., marking an increase of 189.00 Cr..
• For Depreciation, as of Jun 2025, the value is 78.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 87.00 Cr. (Mar 2025) to 78.00 Cr., marking a decrease of 9.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 330.00 Cr.. The value appears to be declining and may need further review. It has decreased from 350.00 Cr. (Mar 2025) to 330.00 Cr., marking a decrease of 20.00 Cr..
• For Tax %, as of Jun 2025, the value is 18.00%. The value appears to be improving (decreasing) as expected. It has decreased from 21.00% (Mar 2025) to 18.00%, marking a decrease of 3.00%.
• For Net Profit, as of Jun 2025, the value is 271.00 Cr.. The value appears to be declining and may need further review. It has decreased from 277.00 Cr. (Mar 2025) to 271.00 Cr., marking a decrease of 6.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 15.66. The value appears strong and on an upward trend. It has increased from 11.68 (Mar 2025) to 15.66, marking an increase of 3.98.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:26 am

Growth

Last Updated: September 5, 2025, 3:00 am

Balance Sheet

Last Updated: October 10, 2025, 1:55 pm

Below is a detailed analysis of the balance sheet data for Dilip Buildcon Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 146.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 146.00 Cr..
• For Reserves, as of Mar 2025, the value is 4,918.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,223.00 Cr. (Mar 2024) to 4,918.00 Cr., marking an increase of 695.00 Cr..
• For Borrowings, as of Mar 2025, the value is 9,525.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 7,240.00 Cr. (Mar 2024) to 9,525.00 Cr., marking an increase of 2,285.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 5,120.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,030.00 Cr. (Mar 2024) to 5,120.00 Cr., marking an increase of 90.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 19,709.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16,640.00 Cr. (Mar 2024) to 19,709.00 Cr., marking an increase of 3,069.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,427.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,531.00 Cr. (Mar 2024) to 1,427.00 Cr., marking a decrease of 104.00 Cr..
• For CWIP, as of Mar 2025, the value is 3,689.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,832.00 Cr. (Mar 2024) to 3,689.00 Cr., marking an increase of 857.00 Cr..
• For Investments, as of Mar 2025, the value is 832.00 Cr.. The value appears to be declining and may need further review. It has decreased from 857.00 Cr. (Mar 2024) to 832.00 Cr., marking a decrease of 25.00 Cr..
• For Other Assets, as of Mar 2025, the value is 13,761.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,420.00 Cr. (Mar 2024) to 13,761.00 Cr., marking an increase of 2,341.00 Cr..
• For Total Assets, as of Mar 2025, the value is 19,709.00 Cr.. The value appears strong and on an upward trend. It has increased from 16,640.00 Cr. (Mar 2024) to 19,709.00 Cr., marking an increase of 3,069.00 Cr..

However, the Borrowings (9,525.00 Cr.) are higher than the Reserves (4,918.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Dilip Buildcon Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 57.44. This value is within the healthy range. It has increased from 13.75 (Mar 24) to 57.44, marking an increase of 43.69.
• For Diluted EPS (Rs.), as of Mar 25, the value is 51.71. This value is within the healthy range. It has increased from 13.36 (Mar 24) to 51.71, marking an increase of 38.35.
• For Cash EPS (Rs.), as of Mar 25, the value is 81.12. This value is within the healthy range. It has increased from 39.65 (Mar 24) to 81.12, marking an increase of 41.47.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 346.35. It has increased from 298.85 (Mar 24) to 346.35, marking an increase of 47.50.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 346.35. It has increased from 298.85 (Mar 24) to 346.35, marking an increase of 47.50.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 773.98. It has decreased from 821.52 (Mar 24) to 773.98, marking a decrease of 47.54.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 156.43. This value is within the healthy range. It has increased from 107.05 (Mar 24) to 156.43, marking an increase of 49.38.
• For PBIT / Share (Rs.), as of Mar 25, the value is 132.75. This value is within the healthy range. It has increased from 81.15 (Mar 24) to 132.75, marking an increase of 51.60.
• For PBT / Share (Rs.), as of Mar 25, the value is 67.10. This value is within the healthy range. It has increased from 33.63 (Mar 24) to 67.10, marking an increase of 33.47.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 57.44. This value is within the healthy range. It has increased from 13.75 (Mar 24) to 57.44, marking an increase of 43.69.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 43.83. This value is within the healthy range. It has increased from 13.27 (Mar 24) to 43.83, marking an increase of 30.56.
• For PBDIT Margin (%), as of Mar 25, the value is 20.21. This value is within the healthy range. It has increased from 13.03 (Mar 24) to 20.21, marking an increase of 7.18.
• For PBIT Margin (%), as of Mar 25, the value is 17.15. This value is within the healthy range. It has increased from 9.87 (Mar 24) to 17.15, marking an increase of 7.28.
• For PBT Margin (%), as of Mar 25, the value is 8.66. This value is below the healthy minimum of 10. It has increased from 4.09 (Mar 24) to 8.66, marking an increase of 4.57.
• For Net Profit Margin (%), as of Mar 25, the value is 7.42. This value is within the healthy range. It has increased from 1.67 (Mar 24) to 7.42, marking an increase of 5.75.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.66. This value is below the healthy minimum of 8. It has increased from 1.61 (Mar 24) to 5.66, marking an increase of 4.05.
• For Return on Networth / Equity (%), as of Mar 25, the value is 12.65. This value is below the healthy minimum of 15. It has increased from 4.44 (Mar 24) to 12.65, marking an increase of 8.21.
• For Return on Capital Employeed (%), as of Mar 25, the value is 14.84. This value is within the healthy range. It has increased from 12.04 (Mar 24) to 14.84, marking an increase of 2.80.
• For Return On Assets (%), as of Mar 25, the value is 3.25. This value is below the healthy minimum of 5. It has increased from 1.16 (Mar 24) to 3.25, marking an increase of 2.09.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 1.37. This value exceeds the healthy maximum of 1. It has increased from 1.16 (Mar 24) to 1.37, marking an increase of 0.21.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.88. This value exceeds the healthy maximum of 1. It has increased from 1.66 (Mar 24) to 1.88, marking an increase of 0.22.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.62. It has decreased from 0.74 (Mar 24) to 0.62, marking a decrease of 0.12.
• For Current Ratio (X), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 1.5. It has increased from 1.32 (Mar 24) to 1.48, marking an increase of 0.16.
• For Quick Ratio (X), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 1. It has increased from 0.81 (Mar 24) to 0.95, marking an increase of 0.14.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.25. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 3.25, marking an increase of 3.25.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 2.28. This value is below the healthy minimum of 20. It has increased from 0.75 (Mar 24) to 2.28, marking an increase of 1.53.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 20. It has increased from 0.25 (Mar 24) to 1.48, marking an increase of 1.23.
• For Earning Retention Ratio (%), as of Mar 25, the value is 97.72. This value exceeds the healthy maximum of 70. It has decreased from 99.25 (Mar 24) to 97.72, marking a decrease of 1.53.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 98.52. This value exceeds the healthy maximum of 70. It has decreased from 99.75 (Mar 24) to 98.52, marking a decrease of 1.23.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.83. This value is below the healthy minimum of 3. It has increased from 1.55 (Mar 24) to 1.83, marking an increase of 0.28.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 3. It has increased from 0.88 (Mar 24) to 1.44, marking an increase of 0.56.
• For Enterprise Value (Cr.), as of Mar 25, the value is 15,519.02. It has increased from 13,188.36 (Mar 24) to 15,519.02, marking an increase of 2,330.66.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.37. This value is within the healthy range. It has increased from 1.10 (Mar 24) to 1.37, marking an increase of 0.27.
• For EV / EBITDA (X), as of Mar 25, the value is 6.79. This value is within the healthy range. It has decreased from 8.43 (Mar 24) to 6.79, marking a decrease of 1.64.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.61. This value is below the healthy minimum of 1. It has increased from 0.55 (Mar 24) to 0.61, marking an increase of 0.06.
• For Retention Ratios (%), as of Mar 25, the value is 97.71. This value exceeds the healthy maximum of 70. It has decreased from 99.24 (Mar 24) to 97.71, marking a decrease of 1.53.
• For Price / BV (X), as of Mar 25, the value is 1.37. This value is within the healthy range. It has decreased from 1.53 (Mar 24) to 1.37, marking a decrease of 0.16.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.61. This value is below the healthy minimum of 1. It has increased from 0.55 (Mar 24) to 0.61, marking an increase of 0.06.
• For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.09, marking an increase of 0.07.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness